0.001
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AngioSoma Inc (PK) | SOAN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.001 | 0.0008 | 0.0011 | 0.001 | 0.001 | 13:14:47 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.0008 | 0.001 | 0.0003 | 27.27% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 46 | 6,869,318 | $ 0.000962 | $ 6,608 | 11,965,286 | 0.0006 - 0.0209 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:39:03 | 50,000 | $ 0.001 | USD |
AngioSoma (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 304.28k | 304.28M | 12.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 9.99k | $ - | 0.00% | - | - |
AngioSoma (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SOAN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0008 | 0.0012 | 0.0006 | 0.0009061 | 23,429,133 | 0.0002 | 25.0% |
| 1 Month | 0.0011 | 0.0013 | 0.0006 | 0.0009058 | 17,860,576 | -0.0001 | -9.09% |
| 3 Months | 0.0009 | 0.00205 | 0.0006 | 0.0010538 | 12,446,429 | 0.0001 | 11.11% |
| 6 Months | 0.0034 | 0.0059 | 0.0006 | 0.0014209 | 8,228,381 | -0.0024 | -70.59% |
| 1 Year | 0.0077 | 0.0209 | 0.0006 | 0.0030867 | 5,734,608 | -0.0067 | -87.01% |
| 3 Years | 0.041 | 0.17 | 0.0006 | 0.0062877 | 2,513,223 | -0.04 | -97.56% |
| 5 Years | 0.51 | 2.60 | 0.0006 | 0.008358 | 1,551,606 | -0.509 | -99.8% |
AngioSoma (PK) Description
| AngioSoma, Inc., a Nevada corporation, is a clinical stage biotechnology company focused on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease (PAD). The Company is developing its lead product, a drug candidate called LiprostinTM for the treatment of peripheral artery disease, or PAD, which has completed FDA Phase I and three Phase II clinical trials. We are in discussions with several contract research organizations for completion of our FDA protocol for Phase III and submission of our new drug application for marketing in the US and its territories. |
